Cdk5 at crossroads of protein oligomerization in neurodegenerative diseases: facts and hypotheses - PubMed (original) (raw)
Review
. 2016 Jan;136(2):222-33.
doi: 10.1111/jnc.13365. Epub 2015 Oct 14.
Affiliations
- PMID: 26376455
- DOI: 10.1111/jnc.13365
Free article
Review
Cdk5 at crossroads of protein oligomerization in neurodegenerative diseases: facts and hypotheses
Anna Wilkaniec et al. J Neurochem. 2016 Jan.
Free article
Abstract
Cyclin-dependent kinase 5 (Cdk5) is involved in proper neurodevelopment and brain function and serves as a switch between neuronal survival and death. Overactivation of Cdk5 is associated with many neurodegenerative disorders such as Alzheimer's or Parkinson's diseases. It is believed that in those diseases Cdk5 may be an important link between disease-initiating factors and cell death effectors. A common hallmark of neurodegenerative disorders is incorrect folding of specific proteins, thus leading to their intra- and extracellular accumulation in the nervous system. Abnormal Cdk5 signaling contributes to dysfunction of individual proteins and has a substantial role in either direct or indirect interactions of proteins common to, and critical in, different neurodegenerative diseases. While the roles of Cdk5 in α-synuclein (ASN) - tau or β-amyloid peptide (Aβ) - tau interactions are well documented, its contribution to many other pertinent interactions, such as that of ASN with Aβ, or interactions of the Aβ - ASN - tau triad with prion proteins, did not get beyond plausible hypotheses and remains to be proven. Understanding of the exact position of Cdk5 in the deleterious feed-forward loop critical for development and progression of neurodegenerative diseases may help designing successful therapeutic strategies of several fatal neurodegenerative diseases. Cyclin-dependent kinase 5 (Cdk5) is associated with many neurodegenerative disorders such as Alzheimer's or Parkinson's diseases. It is believed that in those diseases Cdk5 may be an important factor involved in protein misfolding, toxicity and interaction. We suggest that Cdk5 may contribute to the vicious circle of neurotoxic events involved in the pathogenesis of different neurodegenerative diseases.
Keywords: Alzheimer's disease; Parkinson's disease; cyclin-dependent kinase 5; misfolded proteins; neurodegeneration.
© 2015 International Society for Neurochemistry.
Similar articles
- Role of cyclin-dependent kinase 5 in the neurodegenerative process triggered by amyloid-Beta and prion peptides: implications for Alzheimer's disease and prion-related encephalopathies.
Lopes JP, Oliveira CR, Agostinho P. Lopes JP, et al. Cell Mol Neurobiol. 2007 Nov;27(7):943-57. doi: 10.1007/s10571-007-9224-3. Epub 2007 Oct 27. Cell Mol Neurobiol. 2007. PMID: 17965932 - Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein.
Martinez-Valbuena I, Valenti-Azcarate R, Amat-Villegas I, Marcilla I, Marti-Andres G, Caballero MC, Riverol M, Tuñon MT, Fraser PE, Luquin MR. Martinez-Valbuena I, et al. Acta Neuropathol Commun. 2021 Apr 8;9(1):64. doi: 10.1186/s40478-021-01171-0. Acta Neuropathol Commun. 2021. PMID: 33832546 Free PMC article. - A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons.
Zheng YL, Kesavapany S, Gravell M, Hamilton RS, Schubert M, Amin N, Albers W, Grant P, Pant HC. Zheng YL, et al. EMBO J. 2005 Jan 12;24(1):209-20. doi: 10.1038/sj.emboj.7600441. Epub 2004 Dec 9. EMBO J. 2005. PMID: 15592431 Free PMC article. - Cyclin-dependent kinase 5--a neuronal killer?
Guo Q. Guo Q. Sci Aging Knowledge Environ. 2003 Dec 17;2003(50):pe36. doi: 10.1126/sageke.2003.50.pe36. Sci Aging Knowledge Environ. 2003. PMID: 14681576 Review. - Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
Ritchie DL, Barria MA. Ritchie DL, et al. Biomolecules. 2021 Feb 2;11(2):207. doi: 10.3390/biom11020207. Biomolecules. 2021. PMID: 33540845 Free PMC article. Review.
Cited by
- Protein nanocondensates: the next frontier.
Toledo PL, Gianotti AR, Vazquez DS, Ermácora MR. Toledo PL, et al. Biophys Rev. 2023 Aug 9;15(4):515-530. doi: 10.1007/s12551-023-01105-1. eCollection 2023 Aug. Biophys Rev. 2023. PMID: 37681092 Free PMC article. Review. - Using the shared genetics of dystonia and ataxia to unravel their pathogenesis.
Nibbeling EA, Delnooz CC, de Koning TJ, Sinke RJ, Jinnah HA, Tijssen MA, Verbeek DS. Nibbeling EA, et al. Neurosci Biobehav Rev. 2017 Apr;75:22-39. doi: 10.1016/j.neubiorev.2017.01.033. Epub 2017 Jan 28. Neurosci Biobehav Rev. 2017. PMID: 28143763 Free PMC article. Review. - Differential role of melatonin in healthy brain aging: a systematic review and meta-analysis of the SAMP8 model.
Sumsuzzman DM, Khan ZA, Choi J, Hong Y. Sumsuzzman DM, et al. Aging (Albany NY). 2021 Apr 2;13(7):9373-9397. doi: 10.18632/aging.202894. Epub 2021 Apr 2. Aging (Albany NY). 2021. PMID: 33811754 Free PMC article. - Beta-amyloid 1-42 monomers, but not oligomers, produce PHF-like conformation of Tau protein.
Manassero G, Guglielmotto M, Zamfir R, Borghi R, Colombo L, Salmona M, Perry G, Odetti P, Arancio O, Tamagno E, Tabaton M. Manassero G, et al. Aging Cell. 2016 Oct;15(5):914-23. doi: 10.1111/acel.12500. Epub 2016 Jul 12. Aging Cell. 2016. PMID: 27406053 Free PMC article. - Site-specific phosphorylation of Fbxw7 by Cdk5/p25 and its resulting decreased stability are linked to glutamate-induced excitotoxicity.
Ko YU, Kim C, Lee J, Kim D, Kim Y, Yun N, Oh YJ. Ko YU, et al. Cell Death Dis. 2019 Aug 2;10(8):579. doi: 10.1038/s41419-019-1818-4. Cell Death Dis. 2019. PMID: 31371703 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical